Evidence map›Paper›PMID 34811449›Full record

ArticleScientific reports2021

MUC1 ectodomain is a flagellin-targeting decoy receptor and biomarker operative during Pseudomonas aeruginosa lung infection.

Avelino C Verceles, Pavan Bhat, Zain Nagaria, Destiny Martin, Harsh Patel, Afua Ntem-Mensah, Sang W Hyun, Andrea Hahn, Jean Jeudy, Alan S Cross and 2 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
1.5field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it, 12 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Review
  5. MUC1 in the upper-lower airway inflammatory continuum: an endotype-centered perspective.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2025
    Review
  6. Observational
  7. iScience · 2024
    Article
  8. Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 1 country.

Avelino C VercelesDepartment of Medicine, University of Maryland School of Medicine, Baltimore, MD, USA.
Pavan BhatDepartment of Medicine, University of Maryland School of Medicine, Baltimore, MD, USA.
Zain NagariaDepartment of Medicine, University of Maryland School of Medicine, Baltimore, MD, USA.
Destiny MartinDepartment of Medicine, University of Maryland School of Medicine, Baltimore, MD, USA.
Harsh PatelDepartment of Medicine, University of Maryland School of Medicine, Baltimore, MD, USA.
Afua Ntem-MensahDepartment of Medicine, University of Maryland School of Medicine, Baltimore, MD, USA.
Sang W HyunDepartment of Medicine, University of Maryland School of Medicine, Baltimore, MD, USA.
Andrea HahnDivision of Infectious Diseases, Children's National Health System, Washington, DC, USA.
Jean JeudyDepartment of Diagnostic Radiology and Nuclear Medicine, University of Maryland School of Medicine, Baltimore, MD, USA.
Alan S CrossDepartment of Medicine, University of Maryland School of Medicine, Baltimore, MD, USA.
Erik P LillehojDepartment of Pediatrics, University of Maryland School of Medicine, Baltimore, MD, USA. elillehoj@som.umaryland.edu.
Simeon E GoldblumDepartment of Medicine, University of Maryland School of Medicine, Baltimore, MD, USA.
University of Maryland, Baltimore · USBaltimore VA Medical Center · USGeorge Washington University · USUnited States Department of Veterans Affairs · US

Funding

Role of Sialidase in Pulmonary Host Defenses and Acute Lung InjuryR01HL086933 · NHLBI · UNIVERSITY OF MARYLAND BALTIMORE · PI CROSS, ALAN S. · 2007 to 2010
$1.8M
MUC1 Biotherapeutics for Pseudomonas aeruginosa InfectionsR21AI144497 · NIAID · UNIVERSITY OF MARYLAND BALTIMORE · PI LILLEHOJ, ERIK P · 2019 to 2020
$425k
BLRD VA I01 BX002352NHLBI NIH HHS R01 HL086933NIAID NIH HHS R21 AI144497NIH HHS AI-144497NIH HHS HL-086933
6 · The paper itself

Abstract

We previously reported that flagellin-expressing Pseudomonas aeruginosa (Pa) provokes NEU1 sialidase-mediated MUC1 ectodomain (MUC1-ED) desialylation and MUC1-ED shedding from murine lungs in vivo. Here, we asked whether Pa in the lungs of patients with ventilator-associated pneumonia might also increase MUC1-ED shedding. The levels of MUC1-ED and Pa-expressed flagellin were dramatically elevated in bronchoalveolar lavage fluid (BALF) harvested from Pa-infected patients, and each flagellin level, in turn, predicted MUC1-ED shedding in the same patient. Desialylated MUC1-ED was only detected in BALF of Pa-infected patients. Clinical Pa strains increased MUC1-ED shedding from cultured human alveolar epithelia, and FlaA and FlaB flagellin-expressing strains provoked comparable levels of MUC1-ED shedding. A flagellin-deficient isogenic mutant generated dramatically reduced MUC1-ED shedding compared with the flagellin-expressing wild-type strain, and purified FlaA and FlaB recapitulated the effect of intact bacteria. Pa:MUC1-ED complexes were detected in the supernatants of alveolar epithelia exposed to wild-type Pa, but not to the flagellin-deficient Pa strain. Finally, human recombinant MUC1-ED dose-dependently disrupted multiple flagellin-driven processes, including Pa motility, Pa biofilm formation, and Pa adhesion to human alveolar epithelia, while enhancing human neutrophil-mediated Pa phagocytosis. Therefore, shed desialylated MUC1-ED functions as a novel flagellin-targeting, Pa-responsive decoy receptor that participates in the host response to Pa at the airway epithelial surface.

Indexed as

A549 CellsAgedBiomarkersBronchoalveolar Lavage FluidFemaleFlagellinHost-Pathogen InteractionsHumansLungMaleMiddle AgedMucin-1MutationNeuraminidasePneumonia, BacterialPneumonia, Ventilator-AssociatedBiomarkersflaA protein, bacteriaflaB flagellinFlagellinMUC1 protein, humanMucin-1NEU1 protein, humanNeuraminidase

Identifiers

PMID34811449
PMCPMC8608881
OpenAlexW3216400994

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.